Adverum Biotechnologies Inc. (Lily)
Company Snapshot
Company Overview
Adverum Biotechnologies Inc. is a clinical-stage gene therapy company focused on addressing unmet medical needs in ocular and rare diseases. It has developed a technique for creating viral vectors that are engineered for enhanced transfection success. The company has utilized viral vector-engineered technology to develop a pipeline of treatments for acute macular degeneration and diabetic retinopathy for clinical use. It develops gene therapy product candidates proposed to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its core capabilities include novel vector discovery, nonclinical and clinical development and pre-commercial planning. Adverum Biotechnologies Inc. has assay development and a current good manufacturing practices (cGMP) quality control, as well as in-house manufacturing expertise, specifically in scalable process development.
Adverum Biotechnologies Inc. (Lily) In Reports
Adverum Biotechnologies Inc. (Lily) In News
Company's Business Segments
- Gene Therapy : The company develop treatments for serious ocular and rare diseases, particularly wet age-related macular degeneration (wet AMD), with a focus on single-administration, intravitreal (IVT) therapies.
Applications/End User Industries
- Healthcare
- Life Sciences
- Gene Therapy